Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
Benzinga via Yahoo Finance· 22 hours agoCue Health Inc (NASDAQ: HLTH) became the first company to receive De Novo authorization from the FDA...
Your Risk of COVID-Linked Smell Loss Is Much Lower Now
WebMD· 1 day agoOne of the signature symptoms of COVID-19 infection in the early months of the pandemic was a loss of the sense of smell. Now, new research finds that is ...
Detecting Neutralizing Antibodies for COVID-19: A Novel Technique Uncovered by MIT Chemists
SciTechDaily· 2 days agoThe method could enable a rapid test to determine whether individuals are producing antibodies that...
Novavax exec says its new COVID shot should work against variants on the rise
Reuters· 3 days agoNovavax Inc's (NVAX.O) head of research and development on Monday said an updated COVID-19 vaccine...
Is COVID causing pink eye?
WKYC Cleveland· 3 days agoWe'd love to blame COVID for everything, and to an extent it's possible that the coronavirus may be responsible for some cases of pink eye. Pink eye is...
For COVID-19 vaccination, the emergency may be over, but the fight continues
Afro· 6 days agoPublic health officials have spent the past two years urging people to get vaccinated and boosted...
96% of Americans Have Some COVID-19 Immunity
Time via Yahoo News· 7 days agoCredit - Jasmin Merdan—Getty Images More than three years into the pandemic, an overwhelming majority of Americans have some level of COVID-19 antibodies...
J&J’s COVID vaccine is dead in the US; FDA revokes authorization
Ars Technica· 2 days agoThe Food and Drug Administration has withdrawn authorization for Johnson & Johnson's COVID-19...
New Texas law bans COVID mask, vaccine and shutdown mandates, but some Republicans want more
The Bryan-College Station Eagle· 13 hours agoEver since the COVID-19 pandemic broke out in 2020, Gov. Greg Abbott has faced nagging scrutiny from...
COVID Shot Should Work Against Emerging Variants: Novavax Exec
Medscape· 2 days agoBecause of that, the company said earlier this year it had begun producing a version of the vaccine to target the currently dominant XBB.1.5 variant of the virus at commercial ...
Yahoo Web Search
Trending Now
